A phase II study of Endostatin in combination with paclitaxel, carboplatin, and radiotherapy in patients with unresectable locally advanced non-small cell lung cancer
Crossref DOI link: https://doi.org/10.1186/s12885-016-2234-0
Published Online: 2016-04-11
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sun, Xiao-Jiang
Deng, Qing-Hua
Yu, Xin-Min
Ji, Yong-Lin
Zheng, Yuan-Da
Jiang, Hao
Xu, Ya-Ping
Ma, Sheng-Lin
License valid from 2016-04-11